
At our Headache Unit, we specialize in the comprehensive evaluation, diagnosis, and management of patients suffering from headache disorders and craniofacial pain syndromes. Our unit integrates expertise, innovation, and compassion to offer individualized care plans tailored to each patient’s unique needs.
Vision & Mission
To provide integrated care to patients suffering from different headache disorders by ongoing research projects and by delivering specialist medical care and support services.
Education
Headache unit annual conferences:
- 3rd International Egyptian Headache Conference (6th – 7th June 2024)
- 2nd International Egyptian Headache Conference (18th – 19th May 2023)
- 1st Egyptian Headache Conference (18th – 20th October 2018)
workshops:
- Headache day “Get with the guidelines”, 12th January 2025 at Ain Shams University
- Headache workshop at 9th Ain Shams International Neurology Conference; 6th November 2024
- Ain Shams Migraine Day 28th November 2023
Clinical Services
Outpatient weekly headache clinic
Nerve Blocks: Ultrasound-guided greater occipital, auriculotemporal, supraorbital, and supratrochlear nerve blocks.
Botulinum Toxin Treatments: Administered according to the latest chronic migraine protocols.
Sphenopalatine Ganglion block ultrasound guided.
Community Services
Migraine Awareness Day on 24th March 2024
Fellowships and Observerships
National and International Collaboration
Publications
- Efficacy and safety of ultrasound-guided peripheral nerve blocks in management of chronic resistant migraine; Journal of headache and pain, 2025
- Identifying idiopathic intracranial hypertension in a hospital-based chronic headache population: Utility of magnetic resonance imaging, magnetic resonance venography and trans-orbital sonography; Cephalalgia, 2024
- Evaluating headache referral trends and practices across different settings in neurology clinics: insights from an international cross-sectional multicenter study; Journal of oral & facial pain and Headache, 2024
- Other primary headache disorders: Data from the HEAD-MENA-A study in Africa, Asia, and the Middle East; Clinical Neurology and Neurosurgery, 2024
- Association of white matter hyperintensities with migraine phenotypes and response to treatment; Acta Neurologica Belgica, 2023
- Cross-sectional, hospital-based analysis of headache types using ICHD-3 criteria in the Middle East, Asia, and Africa: the Head-MENAA study; The journal of headache and pain, 2023
- Comparison between the effectiveness of three prophylactic drugs for vestibular migraine; cinnarizine, propranolol, and topiramate: prospective study; The Egyptian Journal of Otolaryngology, 2023
- Serum CGRP Changes following Ultrasound-Guided Bilateral Greater-Occipital-Nerve Block; Neurology International, 2022
- Characteristics, causes and impact of headache among a sample of physicians working during COVID–19 pandemic; Egypt J Neurol Psychiatry Neurosurg, 2022
- Dilemma of migraine diagnosis and management among non‑neurologists; Egypt J Neurol Psychiatry Neurosurg, 2021
- The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis; Egypt J Neurol Psychiatry Neurosurg, 2020